Sangamo Therapeutics
SGMO
#8981
Rank
NZ$0.23 B
Marketcap
NZ$0.70
Share price
-6.65%
Change (1 day)
-65.48%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.77. In 2024 the company made an earnings per share (EPS) of NZ-$0.89.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-13.98%
2024NZ-$0.89
2022NZ-$2.170.81%
2021NZ-$2.1633.33%
2020NZ-$1.626.9%
2019NZ-$1.5122.54%
2018NZ-$1.231.43%
2017NZ-$1.22-31.37%
2016NZ-$1.7775.86%
2015NZ-$1.0148.72%
2014NZ-$0.68-17.02%
2013NZ-$0.829.3%
2012NZ-$0.75-39.44%
2011NZ-$1.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$11.34-1,581.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.16-120.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.66-3,061.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.12-2,597.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$2.82 268.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.16-2,472.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.73-718.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.21-1,825.86%๐Ÿ‡บ๐Ÿ‡ธ USA